-
For women, up to 20% of all coronary events occur in the absence of traditional major risk factors, and many women with these risk factors do not develop coronary events.
-
-
Torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, has been in development by Pfizer for nearly 15 years.
-
Persons who do not suffer hyperhidrosis (HID) may be surprised to learn that it has been associated with both occupational and physical impairment, as well as limitations in social interaction.
-
A new class of drug has been approved for the treatment of cutaneous T-cell lymphoma (CTCL) such as mycosis fungoides.
-
A simple questionnaire can identify individuals at risk for chronic kidney disease.
-
Gonococcal Infections, CDC's Updated Treatment; Head Lice Malathion First-Line Treatment; Statins, May Cut the Risk of Cataracts; FDA Actions
-
-
There is no doubt now that the cervical length (CL) measurement, obtained with transvaginal ultrasound between 20 and 24 weeks, can give the clinician a very reasonable idea about which patients have the greatest and smallest chances of delivering preterm.
-
Worldwide, coffee is a popular beverage used daily with increasing frequency. Caffeine, a dominant ingredient, has been implicated in many conditions including hormonally active cancer (due to its impact on sex hormone binding globulin [SHBG] homeostasis).